Hürthle cell carcinoma of the thyroid: Retrospective review of 62 patients treated at the Royal Marsden Hospital between 1946 and 2003

European Journal of Surgical Oncology

Volumn 35, Issue 3, 2009, Pages 230-234

  Mills, S C ^a   Haq, M ^b   Smellie, W J B ^a   Harmer, C ^b  

^a CHELSEA AND WESTMINSTER HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

H rthle cell carcinoma; Thyroid

Indexed keywords

RADIOACTIVE IODINE;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER GRADING; CANCER SURGERY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; ONCOCYTOMA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THYROID CARCINOMA; THYROIDECTOMY; TREATMENT OUTCOME; TUMOR BIOPSY; UNIVERSITY HOSPITAL;

EID: 59649108225     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2008.06.007     Document Type: Article

References (26)

1. Ewing J. Neoplastic diseases. 2nd ed. (1928), Saunders, Philadelphia, PA 952-953
2. Hundahl S.A., Fleming I.D., Fremgen A., et al. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the US, 1985-1995. Cancer 83 (1998) 2638-2648
3. Herrera M.F., Hay I.D., Wu P.S., et al. Hurthle cell (oxyphilic) papillary thyroid carcinoma: a variant with more aggressive biologic behavior. World J Surg 16 (1992) 669-674 (discussion 675)
4. Thompson N.W., Dunn E.L., Batsakis J.G., et al. Hurthle cell lesions of the thyroid gland. Surg Gynecol Obstet 139 (1974) 555-560
5. Heimann A., and Moll U. Spinal metastasis of a thyroglobulin-rich Hurthle cell carcinoma detected by fine needle aspiration. Light and electron microscopic study of an unusual case. Acta Cytol 33 (1989) 639-644
6. Clark O.H., and Gerend P.L. Thyrotropin receptor-adenylate cyclase system in Hurthle cell neoplasms. J Clin Endocrinol Metab 61 (1985) 773-778
7. Masood S., Auguste L.J., Westerband A., et al. Differential oncogenic expression in thyroid follicular and Hurthle cell carcinomas. Am J Surg 166 (1993) 366-368
8. LiVolsi V.A., and Baloch Z.W. Follicular neoplasms of the thyroid: view, biases, and experiences. Adv Anat Pathol 11 (2004) 279-287
9. Sobin L.H., and Fleming I.D. TNM classification of malignant tumors. 5th ed. Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 80 (1997) 1803-1804
10. Haq M., and Harmer C. Practical management of thyroid cancer (2006), Springer, London 393-402
11. Lopez-Penabad L., Chiu A.C., Hoff A.O., et al. Prognostic factors in patients with Hurthle cell neoplasms of the thyroid. Cancer 97 (2003) 1186-1194
12. Stojadinovic A., Hoos A., Ghossein R.A., et al. Hurthle cell carcinoma: a 60-year experience. Ann Surg Oncol 9 (2002) 197-203
13. Bhattacharyya N. Survival and prognosis in Hurthle cell carcinoma of the thyroid gland. Arch Otolaryngol Head Neck Surg 129 (2003) 207-210
14. Paunovic I., Krgovic K., Tatic S., et al. Surgery for thyroid Hurthle cell tumours-a single institution experience. Eur J Surg Oncol 32 (2006) 458-461
15. Sanz J., Cerpa F., Dominguez M., et al. [Hurthle cell carcinoma of the thyroid. A 41 years experience]. Rev Med Chil 127 (1999) 821-826
16. Pisanu A., Aste L., Piu S., et al. [Predictive factors for malignancy in Hurthle-cell thyroid neoplasia. Effect of surgical treatment]. Tumori 89 (2003) 223-225
17. Chen H., Nicol T.L., Zeiger M.A., et al. Hurthle cell neoplasms of the thyroid: are there factors predictive of malignancy?. Ann Surg 227 (1998) 542-546
18. Wasvary H., Czako P., Poulik J., et al. Unilateral lobectomy for Hurthle cell adenoma. Am Surg 64 (1998) 729-732 (discussion 732-3)
19. Janser J.C., Pusel J., Rodier J.F., et al. [Hurthle cell tumor of the thyroid gland. Analysis of a series of 33 cases]. J Chir (Paris) 126 (1989) 619-624
20. Grossman R.F., and Clark O.H. Hurthle cell carcinoma. Cancer Control 4 (1997) 13-17
21. 131I whole body scanning after thyroidectomy and ablation for differentiated thyroid cancer. Eur J Endocrinol 150 (2004) 649-653
22. Haq M.H.C. Practical management of thyroid cancer (2006), Springer, London 171-192
23. Foote R.L., Brown P.D., Garces Y.I., et al. Is there a role for radiation therapy in the management of Hurthle cell carcinoma?. Int J Radiat Oncol Biol Phys 56 (2003) 1067-1072
24. Lo C.Y., Chan W.F., Lam K.Y., et al. Follicular thyroid carcinoma: the role of histology and staging systems in predicting survival. Ann Surg 242 (2005) 708-715
25. Brooks J.R., Starnes H.F., Brooks D.C., et al. Surgical therapy for thyroid carcinoma: a review of 1249 solitary thyroid nodules. Surgery 104 (1988) 940-946
26. Duntas L., and Grab-Duntas B.M. Risk and prognostic factors for differentiated thyroid cancer. Hell J Nucl Med 9 (2006) 156-162